Cutaneous and Ocular Toxicology

Editor-in-Chief: A. Wallace Hayes

A. Wallace Hayes, Harvard School of Public Health, Andover, Massachusetts, USA

Cutaneous and Ocular Toxicology is an international journal that covers all types of harm to cutaneous and ocular systems. Areas of particular interest include medical products, consumer and household products, as well as environmental and occupational exposures. In addition to original research papers, the journal publishes short communications, case studies and concise, relevant critical reviews of topics of contemporary significance, such as the cutaneous and ocular effects of chemical warfare toxin and industrial chemical exposure.

To subscribe to Cutaneous and Ocular Toxicology, please submit an enquiry form and an Informa Healthcare representative will promptly contact you to process your order and answer any questions.

To recommend Cutaneous and Ocular Toxicology, please submit a library recommendation form and an Informa Healthcare representative will promptly contact your librarian.

ASSOCIATE EDITORS:

Cutaneous

HOWARD I. MAIBACH, M.D., Department of Dermatology University of California School of Medicine, San Francisco, California 94143

Ocular

STEVEN E. WILSON, M.D., Cole Eye Institute The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195

Editorial Board:

K. E. ANDERSON, M.D., Odense Universitetshospital, Odense, Denmark

S. S. ATHERTON, Ph.D., Medical College of Georgia, Augusta, Georgia

D. A. BASKETTER, Ph.D., Safety and Environmental Assurance Centre, Unilever Colworth Laboratory, Sharnbrook, United Kingdom

E. BERARDESCA, M.D., University of Pavia, Pavia, Italy

E. H. BRAUE JR., Ph.D., Department of the Army, Advanced Assessment Branch, Aberdeen Proving Ground, Maryland

R. L. BRONAUGH, Ph.D., USFDA, Cosmetic Toxicology Branch, Laurel, Maryland

R. P. CASILLAS, Ph.D., Battelle Memorial Institute, Columbus, Ohio

H. F. EDELHAUSER, Ph.D., Emory University School of Medicine, Atlanta, Georgia

P. ELSNER, M.D., Universitätsklinikum Jena, Jena, Germany

M. E. FINI, Ph.D., University of Miami School of Medicine, Miami, Florida

G. F. GERBERICK, Ph.D., The Procter & Gamble Company, Cincinnati, Ohio

B. B. HAYES, M.D., Ph.D., Vanderbilt School of Medicine, Nashville, Tennessee

J. V. JESTER, Ph.D., University of California Irvine, California

I. KIMBER, Ph.D., Faculty of Life Science, University of Manchester, England

A. M. KLIGMAN, M.D., Ph.D., University of Pennsylvania Health System, Philadelphia, Pennsylvania

S. D. KLYCE, Ph.D., Louisiana State University Health Sciences Center, New Orleans, Louisiana

B. J. MEADE, D.V.M., Ph.D., NIOSH/HELD, Morgantown, West Virginia

H. F. MERK, M.D., Universitätsklinikum der RWTH Aachen, Aachen, Germany

R. R. MOHAN, Ph.D., The Cole Eye Institute, Cleveland, Ohio

N. A. MONTEIRO-RIVIERE, Ph.D., DABFE, DABFM, North Carolina State University, Raleigh, North Carolina

S. C. PFLUGFELDER, M.D., Cullen Eye Institute, Houston, Texas

M. K. ROBINSON, Ph.D., The Procter & Gamble Company, Cincinnati, Ohio

G. SCHULTZ, Ph.D., Institute for Wound Research, College of Medicine, University of Florida, Gainesville, Florida

J. L. UBELS, Ph.D., Calivin College, Grand Rapids, Michigan

V. VASILIOU, Ph.D., University of Colorado Health Sciences Center, Denver, Colorado

G. WILSON, O.D., Ph.D., Indiana University, Bloomington, Indiana

F.-S. X. Yu, Ph.D., Wayne State University School of Medicine, Detroit, MI

J. D. ZIESKE, Ph.D., The Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts